三级aa视频在线观看-三级国产-三级国产精品一区二区-三级国产三级在线-三级国产在线

Global EditionASIA 中文雙語Fran?ais
China
Home / China / Health

Chinese scholars publish biologics guideline in international journal

By Chen Meiling | chinadaily.com.cn | Updated: 2025-05-07 20:26
Share
Share - WeChat

A Chinese guideline on the use of biologic agents in treating chronic rhinosinusitis with nasal polyps was recently published in the 2025 China Issue of Allergy, one of the most prestigious journals in the global fields of allergology and clinical immunology.

It focuses on China-specific clinical data, systematically standardizing key aspects of biologic treatment, such as patient selection, therapeutic protocols and efficacy evaluation, providing authoritative guidance for clinical practice.

"Emerging biologics that selectively target key cytokines present a promising therapeutic alternative for patients suffering from severe, uncontrollable chronic rhinosinusitis with nasal polyps," according to the guideline.

It's the first time that Chinese scholars have published a guideline-type document in a top-tier international journal in this field, offering valuable Chinese experience for global biologic applications, said Zhang Luo, president of Beijing Tongren Hospital and guest editor of the issue, at a news conference in Beijing on Wednesday.

"In the last two decades, the problems of allergic diseases have been increasing dramatically in the world. Now we are facing 2 billion patients with allergic diseases, so this is a serious threat to humankind in the future," he said.

"In the past, we primarily relied on nasal corticosteroid sprays and oral antihistamines, both of which are chemical-based medications. These treatments have been widely used and can effectively control symptoms. However, since they require frequent administration (often daily), patients may find them inconvenient. Now, with these new biologics, just about three injections over an allergy season can effectively manage symptoms. In terms of both efficacy and duration of effect, they represent an improvement over traditional treatments," Zhang said.

He said these medicines are now available in major hospitals, such as in his hospital. However, since biologics are relatively new, their cost remains high — for example, a single injection may cost around 1,000 to 2,000 yuan ($138-276). "But as their use becomes more widespread, prices are expected to gradually decrease, making them more accessible to a larger number of patients," he added.

The 2025 China Issue of Allergy includes 32 articles focusing on the latest research progress of Chinese scholars in areas such as the link between environmental pollution and asthma pathogenesis, gut microbiota dysbiosis and allergies, as well as the mechanisms underlying drug hypersensitivity.

Cezmi Akdis, editor-in-chief of the journal Allergy, the official journal of the European Academy of Allergy and Clinical Immunology, praised China's contribution to the study of allergy, which has "immensely increased" in the last two decades.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产日韩一区二区三区在线观看 | 国产精品一区二区久久不卡 | 精品成人乱色一区二区 | 国产成人亚洲精品91专区手机 | 看免费的黄色片 | 东京不太热在线新视频 | 国产成人美女福利在线观看 | 欧美成人免费全网站大片 | 黑人巨大vs北条麻妃在线 | 日韩区在线 | 国产综合久久一区二区三区 | 欧美成人午夜视频免看 | 国产三级网站在线观看 | 亚洲一二三区久久五月天婷婷 | 一级毛片高清免费播放 | 黄色网址视频在线播放 | 欧美日韩国产在线播放 | 国产极品精频在线观看 | 久久乐国产精品亚洲综合18 | 大尺度做爰床戏呻吟免费观 | 99er精品| 亚洲国产综合在线 | 国产区精品视频 | 一区在线播放 | 国内精品免费 | 一级生活毛片 | 欧美黄色一级毛片 | 高清波多野结衣一区二区三区 | 国产一级一片免费播放刺激 | 在线高清一级欧美精品 | 色视频在线观看 | 草草影院ccyy免费看片 | 成人做爰全过程免费看视频 | 免费一区二区三区视频狠狠 | 国产大片91精品免费观看不卡 | 很污很污的网站 | 国产高清视频在线播放 | 国产一区二区日韩欧美在线 | 综合 欧美 国产 视频二区 | 久久国产免费福利永久 | 一区二区在线 |